(Q39185534)

9 September 2017

A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro (English)

1 reference

9 September 2017

1 reference

Janet Myungjin Lee

1

1 reference

9 September 2017

Paulette Mhawech-Fauceglia

2

1 reference

9 September 2017

Nathan Lee

3

1 reference

9 September 2017

Lucineh Cristina Parsanian

4

1 reference

9 September 2017

Yvonne Gail Lin

5

1 reference

9 September 2017

Simon Andrew Gayther

6

1 reference

9 September 2017

Kate Lawrenson

7

1 reference

9 September 2017

language of work or name

1 reference

4 March 2013

1 reference

9 September 2017

Laboratory Investigation

1 reference

9 September 2017

93

1 reference

9 September 2017

5

1 reference

9 September 2017

528-542

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2013.41

9 September 2017

0 references

cites work

Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Induction of three-dimensional assembly of human liver cells by simulated microgravity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

In vitro three-dimensional modelling of human ovarian surface epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Scaffold design and fabrication technologies for engineering tissues--state of the art and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Control of Integrin Expression by Extracellular Matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Spheroid-based drug screen: considerations and practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Ovarian cancer: strategies for overcoming resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Reactivity of a monoclonal antibody with human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Establishment of new ovarian and colon carcinoma cell lines: differentiation is only possible by cytokeratin analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Characterization of four novel epithelial ovarian cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Ovarian cancer spheroids use myosin-generated force to clear the mesothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

E-cadherin expression in human epithelial ovarian cancer and normal ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Common epithelial ovarian tumors. Immunohistochemical intermediate filament profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell-scaffold interaction and chemotherapeutic resistance of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

The inhibitory effect of human interferon alpha on the generation of lymphokine-activated killer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

7 January 2021

Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

7 January 2021

Mechanisms of resistance to cisplatin and alkylating agents.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

7 January 2021

DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

7 January 2021

Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

7 January 2021

Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.41

7 January 2021

10.1038/LABINVEST.2013.41

Identifiers

DOI

1 reference

9 September 2017

1 reference